A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00482950|
Recruitment Status : Unknown
Verified June 2009 by Phenomix.
Recruitment status was: Active, not recruiting
First Posted : June 6, 2007
Last Update Posted : June 8, 2009
|Condition or disease||Intervention/treatment||Phase|
|Type 2 Diabetes Mellitus||Drug: PHX1149T||Phase 2|
Expanded Access : Phenomix has indicated that access to an investigational treatment associated with this study is available outside the clinical trial.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||400 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus|
|Study Start Date :||April 2007|
|Estimated Study Completion Date :||February 2008|
- HbA1c [ Time Frame: 12 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00482950
Show 26 Study Locations
|Study Director:||Hans-Peter Guler, MD||Phenomix Corp.|